SFRP2 and neoplasm: Zebularine can be incorporated into DNA and form covalent complexes with DNMT to competitively inhibit DNMT activity, demethylate tumor suppressor genes, such as SFRP2, Dkk3, and p16, and inhibit tumor cell proliferation, differentiation, and metastasis.